We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Data on the real-world efficacy of the COVID-19 vaccines.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 24 July, approved an adapted Pfizer/BioNTech COVID-19 vaccine (Comirnaty) that targets the JN.1 COVID-19 subvariant.
Use this service to book a COVID-19 vaccination or manage your appointment.
Providing vital research into COVID-19 immunity and vaccine effectiveness nationally.
Vaccination newsletter for health professionals and immunisation practitioners.
From discovery to real-world impact, VDEC equips scientists with the expertise and facilities to navigate each step in the development of vaccines and therapeutics.
A Vaccine Damage Payment is a one-off tax-free payment of £120,000 if you're severely disabled as a result of vaccination against certain diseases - what you'll get, eligibility and applying.
Documents relating to the new coronavirus (COVID-19) vaccination programme.
The VDEC clinical evaluation team works to support vaccine and therapeutic development by providing expertise in immunological and functional assays used to support clinical trials (Phase I to IV)
Information on the presentation, doses and storage of COVID-19 vaccines.
Approval of a change to the licence of Comirnaty COVID-19 vaccine will enable thawing and re-labelling of the vaccine outside of the NHS
Information relating to rare side effects after vaccination.
The vaccine was approved after it was found to meet the UK regulator's standards of safety, quality and effectiveness
General information for British people living abroad about getting a vaccine in the country where they live, with links to guidance from regulatory bodies.
VDEC provides a number of services for vaccines post-licensure
Advice and guidance for healthcare practitioners on the health needs of migrant patients.
Guidance for healthcare practitioners about the coronavirus (COVID-19) vaccination programme.
Coronavirus (COVID-19) vaccination information for public health professionals.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).